[go: up one dir, main page]

ES8205770A1 - Procedimiento para la preparacion de derivados de 2,3-indo- lediona - Google Patents

Procedimiento para la preparacion de derivados de 2,3-indo- lediona

Info

Publication number
ES8205770A1
ES8205770A1 ES497530A ES497530A ES8205770A1 ES 8205770 A1 ES8205770 A1 ES 8205770A1 ES 497530 A ES497530 A ES 497530A ES 497530 A ES497530 A ES 497530A ES 8205770 A1 ES8205770 A1 ES 8205770A1
Authority
ES
Spain
Prior art keywords
formula
derivatives
lediona
indo
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES497530A
Other languages
English (en)
Other versions
ES497530A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES8205770A1 publication Critical patent/ES8205770A1/es
Publication of ES497530A0 publication Critical patent/ES497530A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32Oxygen atoms
    • C07D209/38Oxygen atoms in positions 2 and 3, e.g. isatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE 2,3 INDOLEDIONA Y DE SUS SALES FISIOLOGICAMENTE COMPATIBLES, DE FORMULA (I), EN LA QUE R ES ISOPROPILO O T-BUTILO, R1 ES HIDROGENO O ALQUILO INFERIOR Y R2 ES ALQUILO O ARALQUILO INFERIOORES. CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II) CON UNA AMINA DE FORMULA R-NH2, EN LAS QUE R3 ES HIDROXILO Y R4 ES CLORO O BROMO, O JUNTOS REPRESENTAN UN ATOMO DE OXIGENO, Y R, R1 Y R2 TIENEN EL MISMO SIGNIFICADO QUE EN LA FORMULA (I). LA REACCION SE LLEVA A CABO EN UN DISOLVENTE ORGANICO INERTE TAL COMO METANOL O ETANOL O UN EXCESO DE LA AMINA Y UNA TEMPERATURA ENTRE O C Y LA AMBIENTE. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE LA ANGINA DE PECHO Y ARRITMIAS CARDIACAS Y COMO AGENTES ANTIHIPERTENSIVOS.
ES497530A 1979-12-07 1980-12-06 Procedimiento para la preparacion de derivados de 2,3-indo- lediona Granted ES497530A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7942324 1979-12-07

Publications (2)

Publication Number Publication Date
ES8205770A1 true ES8205770A1 (es) 1982-07-01
ES497530A0 ES497530A0 (es) 1982-07-01

Family

ID=10509706

Family Applications (1)

Application Number Title Priority Date Filing Date
ES497530A Granted ES497530A0 (es) 1979-12-07 1980-12-06 Procedimiento para la preparacion de derivados de 2,3-indo- lediona

Country Status (16)

Country Link
US (1) US4395559A (es)
EP (1) EP0030380A1 (es)
JP (1) JPS5695167A (es)
AR (1) AR226869A1 (es)
AU (1) AU6494680A (es)
DK (1) DK522180A (es)
ES (1) ES497530A0 (es)
FI (1) FI803727L (es)
GR (1) GR72136B (es)
HU (1) HU180620B (es)
IL (1) IL61603A0 (es)
MC (1) MC1357A1 (es)
NO (1) NO803693L (es)
NZ (1) NZ195702A (es)
PT (1) PT72176B (es)
ZA (1) ZA807494B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4593106A (en) * 1984-06-04 1986-06-03 Smithkline Beckman Corporation 4-[2-(dialkylamino)ethyl]-7-hydroxyisatins
US4847863A (en) * 1985-10-03 1989-07-11 Watson Bruce W Expandable modular data modem
AR016384A1 (es) 1997-07-30 2001-07-04 Smithkline Beecham Corp Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.
EP1079859B1 (en) 1998-05-22 2010-07-14 The Board Of Trustees Of The Leland Stanford Junior University Bifunctional molecules and therapies based thereon
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
ES2728225T3 (es) 2009-02-20 2019-10-23 2 Bbb Medicines B V Sistema de administración de fármacos a base de glutatión
KR20190116576A (ko) 2009-05-06 2019-10-14 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1778174A (en) * 1926-05-30 1930-10-14 Gen Aniline Works Inc Substituted isatins and process of preparing them
GB1069343A (en) * 1963-09-10 1967-05-17 Ici Ltd Propanolamine derivatives
CH472404A (de) * 1966-03-04 1969-05-15 Sandoz Ag Verfahren zur Herstellung neuer Indolderivate
SE379196B (es) * 1971-06-24 1975-09-29 Sandoz Ag
US4137331A (en) * 1974-06-19 1979-01-30 Sandoz Ltd. 3-Piperidino-2-hydroxypropoxy substituted-2-indolinones
US4212804A (en) * 1978-12-04 1980-07-15 Sandoz, Inc. Process for the preparation of optionally substituted 2,3-indolinediones

Also Published As

Publication number Publication date
MC1357A1 (fr) 1981-08-10
EP0030380A1 (de) 1981-06-17
ZA807494B (en) 1981-11-25
FI803727A7 (fi) 1981-06-08
DK522180A (da) 1981-06-08
HU180620B (en) 1983-03-28
JPS5695167A (en) 1981-08-01
US4395559A (en) 1983-07-26
AU6494680A (en) 1981-06-11
NO803693L (no) 1981-06-09
AR226869A1 (es) 1982-08-31
PT72176A (en) 1981-01-01
FI803727L (fi) 1981-06-08
NZ195702A (en) 1984-09-28
GR72136B (es) 1983-09-20
PT72176B (en) 1982-07-05
ES497530A0 (es) 1982-07-01
IL61603A0 (en) 1981-01-30

Similar Documents

Publication Publication Date Title
ES8706664A1 (es) Procedimiento para preparar compuestos carbostirilicos
ES8503667A1 (es) Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina.
DK44682A (da) Fremgangsmaade til fremstilling af substituerede imidazolderivater
ES8205770A1 (es) Procedimiento para la preparacion de derivados de 2,3-indo- lediona
ATE22292T1 (de) Pyrimidoquinoxaline, ihre herstellung, ihre verwendung als arzneimittel und diese enthaltende zubereitungen.
IE790630L (en) 2, 6-dialkoxybenzamido-pyrrolidines.
ES465225A1 (es) Procedimiento para la preparacion de n-cicloalcohilmetil-2- fenilamino-imidazolinas-(2).
ES477785A1 (es) Procedimiento para la preparacion de nuevas 2-fenilimino- imidazolidinas sustituidas.
NO871575D0 (no) Fremgangsmaate for fremstilling av 1,5-benztiazepinderivater.
ES8403129A1 (es) Procedimiento para la preparacion de nuevas tienobenzodiazepinonas sustituidas.
NO915010D0 (no) Fremgangsmaate for fremstilling av fenylalkylaminoalkyl-forbindelser
AU539870B2 (en) 2-phenylamino-imidazolines-(2)
IE811212L (en) Substituted phenoxy-aminopropanol derivatives
ES532056A0 (es) Un procedimiento para preparar derivados de 5-halovinil-2'-desoxiuridina.
AU551901B2 (en) Substituted thienobenzodiazepinones
ES480765A1 (es) Procedimiento para la obtencion de 2-guanidinometil-indoli- nas.
AU535927B2 (en) 2-phenylamino-imidazolines
IL61769A0 (en) 2-phenylamino-imidazolines-(2),their preparation and pharmaceutical compositions containing them
AU558033B2 (en) 1-(amino-alkoxy-phenyl)-1-phenyl propanols
AU564739B2 (en) Acridanone derivatives
ES8703421A1 (es) Procedimiento para preparar derivados de pirrolidindiona.
NO833978L (no) Fremgangsmaate for fremstilling av terapeutisk aktive semikarbazid-derivater
ES8102144A2 (es) Procedimiento para la preparacion de derivados de la isoqui-noleina